secwatch.observer — SEC 8-K summary
======================================

Issuer:     GENELUX Corp (GNLX)
CIK:        0001231457
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001493152-26-000989
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genelux prices $20M public offering of 6.7M shares at $3.00
-----------------------------------------------------------

- Priced underwritten public offering of 6,666,667 shares at $3.00 each.
- Gross proceeds of approx. $20M before underwriting discounts and expenses.
- Underwriter granted 30-day option to buy up to 1,000,000 additional shares.
- Proceeds for general corporate purposes including R&D, clinical trials, and working capital.
- Offering expected to close January 9, 2026; sole book-runner Lucid Capital Markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1231457/000149315226000989/0001493152-26-000989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1231457/000149315226000989/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer